Cargando…

Cost-effectiveness of a pressure ulcer quality collaborative

BACKGROUND: A quality improvement collaborative (QIC) in the Dutch long-term care sector (nursing homes, assisted living facilities, home care) used evidence-based prevention methods to reduce the incidence and prevalence of pressure ulcers (PUs). The collaborative consisted of a core team of expert...

Descripción completa

Detalles Bibliográficos
Autores principales: Makai, Peter, Koopmanschap, Marc, Bal, Roland, Nieboer, Anna P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895580/
https://www.ncbi.nlm.nih.gov/pubmed/20515473
http://dx.doi.org/10.1186/1478-7547-8-11
_version_ 1782183262411554816
author Makai, Peter
Koopmanschap, Marc
Bal, Roland
Nieboer, Anna P
author_facet Makai, Peter
Koopmanschap, Marc
Bal, Roland
Nieboer, Anna P
author_sort Makai, Peter
collection PubMed
description BACKGROUND: A quality improvement collaborative (QIC) in the Dutch long-term care sector (nursing homes, assisted living facilities, home care) used evidence-based prevention methods to reduce the incidence and prevalence of pressure ulcers (PUs). The collaborative consisted of a core team of experts and 25 organizational project teams. Our aim was to determine its cost-effectiveness from a healthcare perspective. METHODS: We used a non-controlled pre-post design to establish the change in incidence and prevalence of PUs in 88 patients over the course of a year. Staff indexed data and prevention methods (activities, materials). Quality of life (Qol) weights were assigned to the PU states. We assessed the costs of activities and materials in the project. A Markov model was built based on effectiveness and cost data, complemented with a probabilistic sensitivity analysis. To illustrate the results of longer term, three scenarios were created in which change in incidence and prevalence measures were (1) not sustained, (2) partially sustained, and (3) completely sustained. RESULTS: Incidence of PUs decreased from 15% to 4.5% for the 88 patients. Prevalence decreased from 38.6% to 22.7%. Average Quality of Life (Qol) of patients increased by 0.02 Quality Adjusted Life Years (QALY)s in two years; healthcare costs increased by €2000 per patient; the Incremental Cost-effectiveness Ratio (ICER) was between 78,500 and 131,000 depending on whether the changes in incidence and prevalence of PU were sustained. CONCLUSIONS: During the QIC PU incidence and prevalence significantly declined. When compared to standard PU care, the QIC was probably more costly and more effective in the short run, but its long-term cost-effectiveness is questionable. The QIC can only be cost-effective if the changes in incidence and prevalence of PU are sustained.
format Text
id pubmed-2895580
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28955802010-07-02 Cost-effectiveness of a pressure ulcer quality collaborative Makai, Peter Koopmanschap, Marc Bal, Roland Nieboer, Anna P Cost Eff Resour Alloc Research BACKGROUND: A quality improvement collaborative (QIC) in the Dutch long-term care sector (nursing homes, assisted living facilities, home care) used evidence-based prevention methods to reduce the incidence and prevalence of pressure ulcers (PUs). The collaborative consisted of a core team of experts and 25 organizational project teams. Our aim was to determine its cost-effectiveness from a healthcare perspective. METHODS: We used a non-controlled pre-post design to establish the change in incidence and prevalence of PUs in 88 patients over the course of a year. Staff indexed data and prevention methods (activities, materials). Quality of life (Qol) weights were assigned to the PU states. We assessed the costs of activities and materials in the project. A Markov model was built based on effectiveness and cost data, complemented with a probabilistic sensitivity analysis. To illustrate the results of longer term, three scenarios were created in which change in incidence and prevalence measures were (1) not sustained, (2) partially sustained, and (3) completely sustained. RESULTS: Incidence of PUs decreased from 15% to 4.5% for the 88 patients. Prevalence decreased from 38.6% to 22.7%. Average Quality of Life (Qol) of patients increased by 0.02 Quality Adjusted Life Years (QALY)s in two years; healthcare costs increased by €2000 per patient; the Incremental Cost-effectiveness Ratio (ICER) was between 78,500 and 131,000 depending on whether the changes in incidence and prevalence of PU were sustained. CONCLUSIONS: During the QIC PU incidence and prevalence significantly declined. When compared to standard PU care, the QIC was probably more costly and more effective in the short run, but its long-term cost-effectiveness is questionable. The QIC can only be cost-effective if the changes in incidence and prevalence of PU are sustained. BioMed Central 2010-06-01 /pmc/articles/PMC2895580/ /pubmed/20515473 http://dx.doi.org/10.1186/1478-7547-8-11 Text en Copyright ©2010 Makai et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Makai, Peter
Koopmanschap, Marc
Bal, Roland
Nieboer, Anna P
Cost-effectiveness of a pressure ulcer quality collaborative
title Cost-effectiveness of a pressure ulcer quality collaborative
title_full Cost-effectiveness of a pressure ulcer quality collaborative
title_fullStr Cost-effectiveness of a pressure ulcer quality collaborative
title_full_unstemmed Cost-effectiveness of a pressure ulcer quality collaborative
title_short Cost-effectiveness of a pressure ulcer quality collaborative
title_sort cost-effectiveness of a pressure ulcer quality collaborative
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895580/
https://www.ncbi.nlm.nih.gov/pubmed/20515473
http://dx.doi.org/10.1186/1478-7547-8-11
work_keys_str_mv AT makaipeter costeffectivenessofapressureulcerqualitycollaborative
AT koopmanschapmarc costeffectivenessofapressureulcerqualitycollaborative
AT balroland costeffectivenessofapressureulcerqualitycollaborative
AT nieboerannap costeffectivenessofapressureulcerqualitycollaborative